Yüklüyor......
Methotrexate and rheumatoid arthritis associated interstitial lung disease
QUESTION ADDRESSED BY THE STUDY: Methotrexate (MTX) is a key anchor drug for rheumatoid arthritis (RA) management. Fibrotic interstitial lung disease (ILD) is a common complication of RA. Whether MTX exposure increases the risk of ILD in patients with RA is disputed. We aimed to evaluate the associa...
Kaydedildi:
| Yayımlandı: | Eur Respir J |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8212188/ https://ncbi.nlm.nih.gov/pubmed/32646919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00337-2020 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|